Mobile App

Google Play Apple Store
Advances in the Clinical Management of Hereditary Angioedema Standard of Care, New and Emerging Therapies, Patient-Centered Care & Shared Decision-making - Updated 5/27/21
Certified CME/CNE/CPE Activity - Lecture Library Slide Set
The Clinical Viewpoints Hereditary Angioedema lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slides developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

The field of hereditary angioedema (HAE) has recently evolved with the advent of new and forthcoming diagnostic and treatment measures. In particular, the shift toward oral medications will most certainly improve the quality of life for HAE patients. This lecture provides an overview of current diagnostic and treatment procedures recommended by the World Allergy Organization (WAO) and the United States Hereditary Angioedema Association Medical Advisory Board (US HAEA MAB) and summarizes forthcoming new advances in the field of HAE.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.
Review the slides by selecting the View Slide Kit button on the right. Claim 1 AMA, ANCC, or ACPE credit/contact hour per slide kit after completion of a brief posttest/evaluation.
Marc Riedl, MD, MS
Marc Riedl, MD, MS
Professor of Medicine
University of California, San Diego
Clinical Director - US HAEA Angioedema Center



20

Supported by an independent educational grant from BioCryst Pharmaceuticals


Launch Date: February 16, 2021

Release Date: February 10, 2021

Expiration Date: January 31, 2022

January 31, 2022
Mini Module
6963
SSLectureLibrary_WebBanner.HAE(1150).png
Allergy-Immunology